Navigation Links
Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
Date:5/20/2009

NEW YORK, May 20 /PRNewswire/ -- Carl C. Icahn announced today that three influential independent proxy voting advisory services, RiskMetrics Group, Glass Lewis & Co and PROXY Governance, Inc., have recommended that stockholders of Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) support stockholder nominees for election to the Board of Directors of Amylin's at the 2009 Annual Meeting of Stockholders.

  • RiskMetrics Group has recommended that Amylin stockholders vote FOR the election of our nominee, Dr. Alexander J. Denner and FOR the election of Eastbourne nominees, Dr. Kathleen Behrens and Charles Fleischman.
  • Glass Lewis & Co has recommended that Amylin stockholders vote FOR the election of our nominee Dr. Alexander J. Denner and Eastbourne nominees, Dr. Kathleen Behrens and Jay Sherwood.
  • PROXY Governance, Inc. has recommended Amylin stockholders vote FOR the election of our nominees, Dr. Alexander J. Denner and Dr. Thomas Deuel and Eastbourne nominees, Dr. Kathleen Behrens, Charles Fleischman and Jay Sherwood.

In order to follow any of the above recommendations, which were made by three leading independent proxy voting advisory services, stockholders CANNOT use the blue proxy card since the names of the nominees of Icahn and Eastbourne cannot be written in. To reiterate, stockholders should NOT vote the blue proxy card because the blue proxy card will NOT allow stockholders, among other things, to vote for either of our nominees (Dr. Alexander J. Denner and Dr. Thomas Deuel).

We urge stockholders to use our GOLD proxy card to elect Dr. Alexander J. Denner and Dr. Thomas Deuel. The GOLD proxy card will allow stockholders to vote for Dr. Alexander J. Denner and Dr. Thomas Deuel and will have the effect of voting for the Eastbourne nominees as well as the seven management nominees described thereon. If you wish to withhold authority for any of our nominees or any of the nominees of Eastbourne or any of the seven management nominees you may mark the "for all except" box and write the name of the nominees you do not support.

Stockholders are reminded that they CANNOT vote the blue proxy card to vote for any of our nominees or any of the nominees of Eastbourne and are urged to support our nominees on our GOLD proxy card.

If you have any questions about voting your shares, please call Edward McCarthy or Richard Grubaugh of D.F. King & Co., Inc at (212) 269-5550.

ON MAY 6, 2009, THE PARTICIPANTS FILED A DEFINITIVE PROXY STATEMENT WITH THE SECURITIES AND EXCHANGE COMMISSION. SECURITY HOLDERS ARE ADVISED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER DOCUMENTS RELATED TO THE SOLICITATION OF PROXIES BY CARL C. ICAHN, DR. ALEXANDER J. DENNER, DR. THOMAS F. DEUEL, MAYU SRIS, JEFFREY MECKLER, DR. ERIC ENDE, ICAHN PARTNERS LP, ICAHN PARTNERS MASTER FUND LP, ICAHN PARTNERS MASTER FUND II LP, ICAHN PARTNERS MASTER FUND III LP, ICAHN ENTERPRISES G.P. INC., ICAHN ENTERPRISES HOLDINGS L.P., IPH GP LLC, ICAHN CAPITAL L.P., ICAHN ONSHORE LP, ICAHN OFFSHORE LP, BECKTON CORP., AND CERTAIN OF THEIR RESPECTIVE AFFILIATES FROM THE STOCKHOLDERS OF AMYLIN PHARMACEUTICALS, INC. FOR USE AT ITS ANNUAL MEETING, BECAUSE THEY CONTAIN IMPORTANT INFORMATION, INCLUDING INFORMATION RELATING TO THE PARTICIPANTS. THE DEFINITIVE PROXY STATEMENT AND A FORM OF PROXY IS AVAILABLE TO STOCKHOLDERS OF AMYLIN PHARMACEUTICALS INC. FROM THE PARTICIPANTS AT NO CHARGE AND IS ALSO AVAILABLE AT NO CHARGE AT THE SECURITIES AND EXCHANGE COMMISSION'S WEBSITE AT HTTP://WWW.SEC.GOV OR BY CONTACTING D.F. KING & CO., INC. BY TELEPHONE TOLL FREE AT 1-800-488-8075.


'/>"/>
SOURCE Carl C. Icahn
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Three Michigan Companies Expand in Ann Arbor with MEDC Support
2. Air Products Sells Three U.S. Healthcare Businesses to Landauer-Metropolitan
3. Swine Flu Closes Three Schools in NYC
4. Study compares formulations of three aspirin types
5. Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009
6. Bertram Receives Organizational Innovation Award at AONE Conference -- Award Sponsor B. E. Smith Also Announces Funding for Three Seed Grants
7. Obama Administration Might Recommend Three Flu Shots for Americans This Fall
8. Three-Quarters of Durable Medical Equipment Providers Have Prepared for Pandemic Flu, According to a May 1 Survey by American Association for Homecare
9. Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
10. U.S. Food and Drug Administration Extends Action Date for Inhaled Treprostinil (Tyvaso) New Drug Application by Three Months
11. Pharos Innovations and Clients to Showcase Three Client Case Studies at Upcoming ATA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Children ... to more adverse experiences than children in the general population. That’s because foster ... neglect or other family challenges. While no fault of their own, youth who ...
(Date:4/28/2017)... ... ... People are starting to accept that hearing aids can be helpful and ... it had when great-grandpa wore his hearing aids years ago,” said Dr. Maura Marks, ... American Speaker Series (NASS) segment. “He probably wore an iPod-size hearing aid on ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... Manager for the North East region. Côté has 20+ years of experience within ... to Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Rob Lowe ... and now he has leant his presence to an educational purpose as the host ... one important one being cancer. In a recent episode, the series focuses on thyroid ...
(Date:4/27/2017)... ... April 27, 2017 , ... The Incentive Research Foundation is ... Nudge Guide," a groundbreaking analysis of how behavioral economics can be applied to ... to IRR programs, the report highlights proven behavioral economics approaches and the powerful ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
Breaking Medicine Technology: